164 related articles for article (PubMed ID: 22724525)
1. Crystal structure of xenotropic murine leukaemia virus-related virus (XMRV) ribonuclease H.
Kim JH; Kang S; Jung SK; Yu KR; Chung SJ; Chung BH; Erikson RL; Kim BY; Kim SJ
Biosci Rep; 2012 Oct; 32(5):455-63. PubMed ID: 22724525
[TBL] [Abstract][Full Text] [Related]
2. Structural and inhibition studies of the RNase H function of xenotropic murine leukemia virus-related virus reverse transcriptase.
Kirby KA; Marchand B; Ong YT; Ndongwe TP; Hachiya A; Michailidis E; Leslie MD; Sietsema DV; Fetterly TL; Dorst CA; Singh K; Wang Z; Parniak MA; Sarafianos SG
Antimicrob Agents Chemother; 2012 Apr; 56(4):2048-61. PubMed ID: 22252812
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures of the reverse transcriptase-associated ribonuclease H domain of xenotropic murine leukemia-virus related virus.
Zhou D; Chung S; Miller M; Grice SF; Wlodawer A
J Struct Biol; 2012 Mar; 177(3):638-45. PubMed ID: 22366278
[TBL] [Abstract][Full Text] [Related]
4. The solution structure of the prototype foamy virus RNase H domain indicates an important role of the basic loop in substrate binding.
Leo B; Schweimer K; Rösch P; Hartl MJ; Wöhrl BM
Retrovirology; 2012 Sep; 9():73. PubMed ID: 22962864
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the RNase H C helix of the Moloney murine leukemia virus reverse transcriptase reveal defects in polypurine tract recognition.
Lim D; Orlova M; Goff SP
J Virol; 2002 Aug; 76(16):8360-73. PubMed ID: 12134040
[TBL] [Abstract][Full Text] [Related]
6. Biochemical, inhibition and inhibitor resistance studies of xenotropic murine leukemia virus-related virus reverse transcriptase.
Ndongwe TP; Adedeji AO; Michailidis E; Ong YT; Hachiya A; Marchand B; Ryan EM; Rai DK; Kirby KA; Whatley AS; Burke DH; Johnson M; Ding S; Zheng YM; Liu SL; Kodama E; Delviks-Frankenberry KA; Pathak VK; Mitsuya H; Parniak MA; Singh K; Sarafianos SG
Nucleic Acids Res; 2012 Jan; 40(1):345-59. PubMed ID: 21908397
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain.
Najmudin S; Coté ML; Sun D; Yohannan S; Montano SP; Gu J; Georgiadis MM
J Mol Biol; 2000 Feb; 296(2):613-32. PubMed ID: 10669612
[TBL] [Abstract][Full Text] [Related]
8. Folding the ribonuclease H domain of Moloney murine leukemia virus reverse transcriptase requires metal binding or a short N-terminal extension.
Goedken ER; Marqusee S
Proteins; 1998 Oct; 33(1):135-43. PubMed ID: 9741851
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of the RNase H domain of Moloney murine leukemia virus reverse transcriptase.
Nishimura K; Yokokawa K; Hisayoshi T; Fukatsu K; Kuze I; Konishi A; Mikami B; Kojima K; Yasukawa K
Protein Expr Purif; 2015 Sep; 113():44-50. PubMed ID: 25959458
[TBL] [Abstract][Full Text] [Related]
10. RNase H activity: structure, specificity, and function in reverse transcription.
Schultz SJ; Champoux JJ
Virus Res; 2008 Jun; 134(1-2):86-103. PubMed ID: 18261820
[TBL] [Abstract][Full Text] [Related]
11. Structural analysis of monomeric retroviral reverse transcriptase in complex with an RNA/DNA hybrid.
Nowak E; Potrzebowski W; Konarev PV; Rausch JW; Bona MK; Svergun DI; Bujnicki JM; Le Grice SF; Nowotny M
Nucleic Acids Res; 2013 Apr; 41(6):3874-87. PubMed ID: 23382176
[TBL] [Abstract][Full Text] [Related]
12. Structure of human RNase H1 complexed with an RNA/DNA hybrid: insight into HIV reverse transcription.
Nowotny M; Gaidamakov SA; Ghirlando R; Cerritelli SM; Crouch RJ; Yang W
Mol Cell; 2007 Oct; 28(2):264-76. PubMed ID: 17964265
[TBL] [Abstract][Full Text] [Related]
13. Structural biochemistry of a type 2 RNase H: RNA primer recognition and removal during DNA replication.
Chapados BR; Chai Q; Hosfield DJ; Qiu J; Shen B; Tainer JA
J Mol Biol; 2001 Mar; 307(2):541-56. PubMed ID: 11254381
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic DNA synthesis fidelity of xenotropic murine leukemia virus-related virus reverse transcriptase.
Barrioluengo V; Wang Y; Le Grice SF; Menéndez-Arias L
FEBS J; 2012 Apr; 279(8):1433-44. PubMed ID: 22340433
[TBL] [Abstract][Full Text] [Related]
15. Construction of an enzymatically active ribonuclease H domain of human immunodeficiency virus type 1 reverse transcriptase.
Stahl SJ; Kaufman JD; Vikić-Topić S; Crouch RJ; Wingfield PT
Protein Eng; 1994 Sep; 7(9):1103-8. PubMed ID: 7530360
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the moloney murine leukemia virus RNase H domain.
Lim D; Gregorio GG; Bingman C; Martinez-Hackert E; Hendrickson WA; Goff SP
J Virol; 2006 Sep; 80(17):8379-89. PubMed ID: 16912289
[TBL] [Abstract][Full Text] [Related]
17. Substitution of a highly basic helix/loop sequence into the RNase H domain of human immunodeficiency virus reverse transcriptase restores its Mn(2+)-dependent RNase H activity.
Keck JL; Marqusee S
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2740-4. PubMed ID: 7535929
[TBL] [Abstract][Full Text] [Related]
18. Substitution of Asp114 or Arg116 in the fingers domain of moloney murine leukemia virus reverse transcriptase affects interactions with the template-primer resulting in decreased processivity.
Gu J; Villanueva RA; Snyder CS; Roth MJ; Georgiadis MM
J Mol Biol; 2001 Jan; 305(2):341-59. PubMed ID: 11124910
[TBL] [Abstract][Full Text] [Related]
19. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
Gao HQ; Sarafianos SG; Arnold E; Hughes SH
J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the polymerase and RNase H activities of human foamy virus reverse transcriptase.
Boyer PL; Stenbak CR; Clark PK; Linial ML; Hughes SH
J Virol; 2004 Jun; 78(12):6112-21. PubMed ID: 15163704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
